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Tlxe authors compared the serum acetylcholinesterase level in the patients of brown sugar depend-
ence and the normal volunteers. Significantly lower level of serum acetylcholinesterase was found 
in patients of brown sugar dependence. 
Opioid dependence is one of the major 
problems we are facing today. Even with the 
best of the availabe treatments, the relapse rate 
remains very high. While treating these patients 
over a period of last five years, it was noticed 
that most of these patients were very much 
aware about their problems and were genuine-
ly interested in getting rid of the addiction. But 
inspite of this good motivation many of them 
would relapse within a short period of 
abstinence. Though the patients attributed the 
relapse to different reasons, it was found that 
the main reason for the relapse was the severe 
craving and the intense desire to consume the 
substance, which occurs during the initial 
withdrawal period and also during the sub-
sequent abstinence period. If this craving can 
be controlled then even the relapse rate can 
be reduced. 
As the various physical symptoms which 
occur during the withdrawal phase seem to have 
a biological basis, like altered levels of 
neurotransmitters and changes in the receptor 
density and sensitivity, it is likely that the men-
tal symptoms of craving also have a similar 
biological basis. So in order to control the 
craving it is necessary to study the biological 
basis for this addiction. 
In this direction various studies have 
been done and at present it is generally believed 
that increased noradrenergic activity plays a 
role in opioid withdrawal. Therefore usually 
attempts are made towards reducing 
noradrenergic activity during the withdrawal 
period to control the symptoms. The use of drug 
Clonidine (a presynaptic alpha-agonist) during 
withdrawal is based on the same principle. 
If we take a look at the signs and 
symptoms which occur during the opioid 
withdrawal states, e.g. watering from the eyes 
and nose, pain in abdomen, diarrhoea and 
vomitting, bodyaches and joint pains, insomnia 
and yawning, piloerection (goose flash), and 
spontaneous ejaculation, it is evident that most 
of these symptoms can not be explained by in-
creased noradrenergic activity. 
These symptoms can either be explained 
by opioid receptor theory or by increased 
cholinergic activity during withdrawal. Since our 
body is basically controlled by sympathetic and 
parasympathetic nervous system, it is likely that 
even opioid system is finally medicated by one of 
these two symptoms only. From the above dis-
cussion it seems that it may not be the adrenergic 
activity but the cholinergic activity which plays a 
role in opioid withdrawal state. 
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To study this hypothesis the ideal thing 
would have been to study the cerebrospinal 
fluid acetylcholine levels of the opioid depend-
ence patients. This was not possible for us since 
the technique of estimating acetylcholine levels 
is relatively difficult and very expensive and also 
unless we have some supportive evidence for 
this hypothesis it is not advisable to do invasive 
procedures like lumber puncture to collect 
cerebrospinal fluid. The other alternative in-
direct method to study Acetylcholine function 
is to study blood acetylcholinesterase (true 
cholinesterase) levels. This is a relatively easy 
method and it may reflect central nervous sys-
tem acetylcholine activity. After keeping in 
mind the limitation of the study, a pilot project 
was taken up to study the blood acetyl-
cholinesterase levels in the opioid dependence 
patients. 
MATERIAL AND METHOD 
12 consecutive patients of opioid de-
pendence (as per DSM-III-criteria) who were 
not on any medical treatment in the past one 
month were selected for the study. After the 
informed consent, 5ml. plain blood was col-
lected within 12 hours of the last consumption 
of brown sugar, (i.e. just at the begining of the 
withdrawal). 
For the control, 12 samples of 5ml. plain 
blood were obtained after the informed con-
sent, from the volunteers who had come to the 
blood bank for blood donation. It was made 
sure that none of these volunteers were consum-
ing brown sugar or opioids in any other forms. 
A special proforma was prepared to col-
lect the required demographic and 
phcnomenological data of the patients and 
volunteers. 
All the collected blood samples were 
analysed by colorimetric method (Ellman et al., 
1961), on auto analyser to determine serum 
acetylcholinesterase (E.C. 3.1.1.7) levels. 
The collected data was then tabulated 
and statistically analysed using unpaired t-test 
and correlation coefficient. 
RESULT 
The index group had the mean ± SD age 
of 27.08±5.59 years, and the control group had 
25.25±5.36 years. There was no significant dif-
ference between the two groups in their age 
(t = 0.82, df=22, p<0.05). All the patients in 
both the groups were males. 
11 out of 12 patients were consuming 
brown sugar for more than two years and 
majority of them were consuming about 2 to 6 
quarters of brown sugar per day. 7 out of 12 
patients consumed it either by smoking or chas-
ing, while 4 patients consumed it only by chasing 
and 1 patient, in addiction to these modes, used 
to take it parenterally. All of them used to take 
charas along with brown sugar while 5 of them 
took other substance also, like alcohol and 
sedative- hypnotic drugs. Out of these, for 5 of 
them it was the first attempts to give up their 
addiction, while the others had relapsed once 
or twice before and 1 patient had relapsed 3 
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The mean ±SD serum aacetyl-
cholineslerase level of the patients in the 
index group was 1831 ±486.67 compared to 
2528+400.15 in the control group. The index 
group had significantly lower serum acetyl-
cholinesterase level as compared to control 
group (t = 3.83, df=22, p<0.001). 
We did not find any correlation between 
serum acetylcholinesterase levels and either 
total duration of consumption (r = 0.1874, 
df= 11, p>0.05) or average quantity of brown 
sugar consumed per day (r = 0.2437, df=ll 
p>0.05). 
DISCUSSION 
Lower serum acetylcholinesterase 
levels have been reported in patients of 
uraemia, shock, anaemia, tuberculosis, cancer, 
malnutrition and cachexia (Mclauchlan, 1988). 
In our sample only 2 patients had tuber-
culosis and none had uraemia, shock or cancer. 
It is likely that due to chronic consumplion of 
opioids they may have developed some degree 
of malnutrition which may be responsible for 
lower serum acetylcholinesterase levels. 
Another factor which was common to all 
the patients was consumption of charas along 
with brown sugar and therefore it's contribution 
to the findings cannot be ruled out. 
As opposed to the above mentioned 
conditions, the conditions in which there is 
increased sympathetic activity like 
thyrotoxicosis, hypertension, alcohol depend-
ence etc. higher than the normal levels of 
serum actylcholinesterase have been 
reported (Mclauchlan, 1988). So our finding 
of lower serum acetylcholinesterase levels in 
patients ofopioid dependence suggests that it 
is very unlikely that increased adrenergic ac-
tivity plays a role in opioid withdrawal. It is 
more likely that the increased cholinergic ac-
tivity plays important role during opioid 
withdrawal, as lower acetylcholinesterase 
levels are associated with increased choliner-
gic activity. 
It is likely that since total duration of 
consumption as well as average quantity of 
brown sugar consumed per day are crude 
parameters, we did not find any correlation 
between them and the scrum acetyl-
cholinesterase levels. 
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